Quantum Biopharma (QNTM) Operating Expenses (2019 - 2026)
Quantum Biopharma (QNTM) posted Operating Expenses of $3.0 million for Q1 2026, up 24.98% sequentially from $2.4 million in Q4 2025, and down 12.69% YoY from $3.4 million in Q1 2025.
Quantum Biopharma (QNTM) Operating Expenses (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Operating Expenses for 8 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Operating Expenses fell 12.69% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.9 million (up 11.88% YoY) and the FY2025 annual result came in at $15.3 million, down 5.17% from the prior year.
- Operating Expenses advanced to $3.0 million in Q1 2026 per QNTM's latest filing, from $2.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $9.8 million in Q1 2023 and troughed at $1.9 million in Q2 2023.
- A 5-year average of $3.9 million and a median of $3.4 million in 2025 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 84.77% in 2024, down 77.07% in 2024.
- Over 5 years, Operating Expenses stood at $5.6 million in 2022, then plunged by 41.38% to $3.3 million in 2023, then slumped by 31.84% to $2.3 million in 2024, then gained by 5.14% to $2.4 million in 2025, then rose by 24.98% to $3.0 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $3.0 million, $2.4 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 541.02 Mn |
| 10 | Quantum Biopharma | 15.47 Mn | 11.82 Mn | - | 2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Mn |
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 4.18 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 9.84 Mn |
| Mar 31, 2022 | 5.65 Mn |
| Jun 30, 2021 | 12.69 Mn |
| Sep 30, 2020 | 13.12 Mn |
| Jun 30, 2020 | 3.48 Mn |
| Mar 31, 2020 | 4.99 Mn |
| Dec 31, 2019 | 9.69 Mn |
| Sep 30, 2019 | 8.42 Mn |